Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (181-190 of 464) with videos related to

Pageof 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trialWilliam J Sandborn, Stefan Schreiber, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2018
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapiesChristopher Ma, Leonardo Guizzetti, Lauren E Cipriano, et al.
BMJ Open|January 14, 2016
Cost-effectiveness analysis of arthroscopic surgery compared with non-operative management for osteoarthritis of the kneeJacquelyn D Marsh, Trevor B Birmingham, J Robert Giffin, et al.
The Cochrane Database of Systematic Reviews|July 22, 2017
Histologic scoring indices for evaluation of disease activity in Crohn's diseaseGregor Novak, Claire E Parker, Rish K Pai, et al.
Gastroenterology|June 26, 2020
Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-AnalysisHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis|March 17, 2023
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION TrialIris Dotan, Brian G Feagan, Virginia Taliadouros, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2015
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future DirectionsLaurent Peyrin-Biroulet, Julián Panés, William J Sandborn, et al.
The American Journal of Gastroenterology|February 28, 2007
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patientsBrian G Feagan, Walter Reinisch, Paul Rutgeerts, et al.
Gut|July 5, 2012
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's diseaseBruce E Sands, Seymour Katz, Douglas C Wolf, et al.
BMJ Open|June 12, 2017
Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyChristopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Pageof 47

Showing results (181-190 of 464) with videos related to

Sort By:
Pageof 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trialWilliam J Sandborn, Stefan Schreiber, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2018
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapiesChristopher Ma, Leonardo Guizzetti, Lauren E Cipriano, et al.
BMJ Open|January 14, 2016
Cost-effectiveness analysis of arthroscopic surgery compared with non-operative management for osteoarthritis of the kneeJacquelyn D Marsh, Trevor B Birmingham, J Robert Giffin, et al.
The Cochrane Database of Systematic Reviews|July 22, 2017
Histologic scoring indices for evaluation of disease activity in Crohn's diseaseGregor Novak, Claire E Parker, Rish K Pai, et al.
Gastroenterology|June 26, 2020
Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-AnalysisHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Journal of Crohn'S & Colitis|March 17, 2023
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION TrialIris Dotan, Brian G Feagan, Virginia Taliadouros, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2015
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future DirectionsLaurent Peyrin-Biroulet, Julián Panés, William J Sandborn, et al.
The American Journal of Gastroenterology|February 28, 2007
The effects of infliximab therapy on health-related quality of life in ulcerative colitis patientsBrian G Feagan, Walter Reinisch, Paul Rutgeerts, et al.
Gut|July 5, 2012
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's diseaseBruce E Sands, Seymour Katz, Douglas C Wolf, et al.
BMJ Open|June 12, 2017
Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyChristopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Pageof 47